毛细支气管炎后早期干预对哮喘发病率的影响  

Effect of early inhaling budesonide on the incidence of asthma after bronchitis

作　　者：黄海忠[1] 李颖红[1] 李玉华[1] 

机构地区：[1]广东省惠州市人民医院儿科,广东惠州516002

出　　处：《实用医院临床杂志》2006年第3期41-42,共2页Practical Journal of Clinical Medicine

摘　　要：目的观察吸入布地奈德(budeson ide)早期干预毛细支气管炎对减少哮喘发病率的影响。方法分组观察毛细支气管炎患儿临床缓解后吸入和不吸入布地奈德,随访2年后哮喘的发病率。结果吸入组患儿发病率12.1%,对照组发病率为44.1%,二者差异有显著性意义(P<0.01)。结论毛细支气管炎缓解后早期吸入布地奈德干预可减低其哮喘发病率,尤其在血清总IgE水平升高的患儿中效果较明显。Objective To investigate the effect of early inhaling budesonide on the incidence of asthma after bronchitis in-duced by respiratory syncytial virus（RSV）. Methods Compare the incidence of asthma in children who had recovered from bronchitis and treated with or without budesonide-inhaling. Results The incidence of asthma in the inhaling group was 12.1% and the control group was 44. 1% ; there was noticeable significance between the two groups （ P 〈 0.01 ）. Conclusion Budesonide- inhaling can obviously reduce the incidence of asthma during the respiratory syncytial virus-induced bronchitis remission, especially in children with a high level of IgE.

关 键 词：毛细支气管炎 哮喘 布地奈德 呼吸道合胞病毒(RSV) 发病率 

分 类 号：R562.2[医药卫生—呼吸系统]